Dr Newell is plenary speaker at the Nature Conference on Inflammatory Diseases
Uncontrolled inflammation is the underlying pathological mechanism of a variety of infectious and non-infectious diseases that together are responsible for a growing burden on human health. Insights into the biology, molecular basis and regulation of inflammation and its role in disease are crucial for exploring novel approaches to modulating the pathological mechanisms in human inflammatory diseases. This Nature Conference will bring together leading international scientists to explore emerging themes in inflammatory mechanisms, innate immune signaling and immune dysregulation, as well as the role of inflammation in the pathogenesis of inflammation-associated diseases, including autoinflammatory diseases, cancer, metabolic syndrome and autoimmune diseases. The conference will also include a session on new technologies in inflammation research, as well as industry and young researcher networking opportunities.
Dr Newell is plenary speaker at the conference ‘From the laboratory to the clinic: Immune-tissue cell interactions’
Dr Newell is co-organizer and speaker at the Keystone Symposia: Single Cell Omics
Single cell omics is a new frontier in biology where genome-wide data is captured at the resolution of individual cells. Single cell high-throughput technologies are being developed in the areas of imaging, mass spectrometry and DNA- and RNA-sequencing, and combinations thereof. In addition, the corresponding software and visualization tools are an active field of research. Single cell omics has important implications for all areas of development, differentiation and cellular decision-making because these can now be studied at unprecedented resolution. Single cell omics methods are also shedding new light on immunity and cancer, due to the heterogeneous cell populations involved in both areas of biology. Therefore, these approaches are revolutionizing basic biology, our understanding of disease and technologies involved in translation to medicine. Since the field is in its infancy and there are few meetings dedicated to this topic, there is an unmet need in the community. This conference enables scientists in the field to congregate and exchange ideas and information about new methods and biological insights. A conference such as this will be of continuing importance until single cell omics technologies become commonplace and integrated into all areas of biology. Single cell omics has important implications for all areas of development, differentiation and cellular decision-making, because these can now be studied at unprecedented resolution. Equally, single cell omics methods are shedding new light on immunity and cancer, due to the heterogeneous cell populations involved in both areas of biology. Therefore, these approaches are revolutionizing both basic biology as well as our understanding of disease, and technologies involved in translation to medicine. Since the field is in its infancy, and there are few meetings dedicated to this topic, there is a huge unmet need in the community to congregate and exchange ideas and information about new methods and the biological insights gained. A meeting such as this will be of continuing importance until single cell omics technologies become commonplace and established, and integrated into all areas of biology.
Dr Newell’s presentation at Immunology 2017: New Horizons
Dr Newell’s presentation at TNFSuperfamily 2017
immunoSCAPE presentation at BioPharma Asia
Dr Newell’s presentation at Keystone Symposia: Cancer Immunology and Immunotherapy
The fields of cancer immunology and immunotherapy continue to make great strides in providing both a comprehensive understanding of the basic mechanisms underlying tumor-immune system interactions and applying this knowledge to the development of effective immune-based cancer therapies. This Keystone Symposia meeting is organized to highlight recent insights into the complex roles of immune components and pathways in controlling or alternatively promoting cancer and to showcase recent uses of cancer vaccines, checkpoint blocking strategies, adoptive cell therapies and cellular engineering approaches, either as mono- or combinatorial therapies, that have resulted in durable, effective and safe therapeutic responses to an increasing number of cancer patients. Part of the meeting will also focus on new, developing technologies that are likely to expand our capacity to monitor the effects of cancer immunotherapy with a precision, refinement and at a level that has not been possible in the past.